A subscription to JoVE is required to view this content. Sign in or start your free trial.
1Department of Ophthalmology,University Hospital RWTH Aachen, 2Experimental Ophthalmology,University of Geneva, 3Department of Ophthalmology,University Hospitals of Geneva, 4Université de Paris, CNRS, INSERM, UTCBS, Unité des technologies Chimiques et Biologiques pour la Santé, 5Chimie ParisTech,PSL Research University, 6Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 7Division of Medical Biotechnology,Paul-Ehrlich-Institute
Chapters
- 00:05Introduction
- 00:57Primary Human RPE Cell Electroporation and Plasmid DNA Preparation
- 01:57Cultivated Primary Human RPE Cell Preparation
- 03:19His-Tagged Pigment Epithelium-Derived Factor (PEDF) Fusion Protein Purification
- 04:57Results: Representative Primary Human RPE Transfection and Genetic Modification Evaluation
- 06:24Conclusion
We have developed a protocol to transfect primary human pigment epithelial cells by electroporation with the gene encoding pigment epithelium-derived factor (PEDF) using the Sleeping Beauty (SB) transposon system. Successful transfection was demonstrated by quantitative polymerase chain reaction (qPCR), immunoblotting, and enzyme-linked immunosorbent assay (ELISA).
